News
-
-
-
COMMUNIQUÉ DE PRESSE
Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Kidoz Inc. reports record second-quarter revenue growth of 37% and first-half revenue growth of 22% in 2026, driven by investments in sales, marketing, and software development -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Biosidus expands biologics manufacturing capacity, strengthening global supply capabilities for agalsidase beta through new bioreactor plant, focusing on rare diseases -
-